Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.03 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |